Denmark, Iceland, Norway Droop AstraZeneca COVID-19 Vaccinations After Blood Clots Report
Denmark, Iceland and Norway have suspended use of the AstraZeneca COVID-19 vaccine as a precaution amid studies of blood clotting in some individuals who have obtained it.
The Danish well being authority stated a demise had been reported within the nation however that “in the meanwhile it can’t be concluded whether or not there’s a hyperlink between the vaccine and the blood clots”.
The usage of the vaccine will probably be suspended till additional discover, the well being authority stated Thursday, however the resolution will probably be reviewed in two weeks.
Shortly after the Danish announcement, Iceland adopted go well with. Hours later, Norwegian well being officers additionally stated they’d additionally droop vaccinations after Denmark’s report.
France and the UK, nevertheless, have dominated out for the second the next lawsuit, stressing that the suspension in different nations “is a precautionary measure”.
Do you want euronews.com? Strive our app to get alerts on our high European tales and all the newest breaking information. It’s accessible on each Apple and Android units.
Austria suspends its batch of vaccines
It comes after Austria suspended a vaccine batch following the demise of a lady attributable to a number of blood clots and the hospitalization of one other with a blockage within the arteries of the lungs.
The batch of vaccines, which included a million doses, was subsequently suspended in 4 different EU nations as a precaution.
The European Medicines Company stated it was reviewing the incidents in addition to all different “blood clot-related circumstances”, however a preliminary examination steered there was no “particular downside” with the lot.
On Tuesday, the medicines regulator stated, 22 instances of blood clotting have been reported among the many three million individuals vaccinated with the AstraZeneca vaccine within the European Financial Space.
“We’re within the midst of the most important and most vital vaccination deployment in Danish historical past. And proper now, we’d like all of the vaccines we will get. Due to this fact, placing one of many vaccines on maintain just isn’t a straightforward resolution, ”stated Søren Brostrøm, director basic of the Danish well being authority.
“However exactly as a result of we’re vaccinating so a lot of them, we additionally want to reply with well timed care once we change into conscious of any severe unwanted effects. We have to make clear this earlier than we will proceed to make use of AstraZeneca’s vaccine.”
The change implies that individuals who obtained their first dose of the AstraZeneca vaccine in Denmark should wait earlier than receiving the second dose, the well being authority stated.
Frontline well being staff aged 65 or older will proceed to obtain vaccination appointments with one of many different two vaccines, they stated.
The authority stated it was not giving up the AstraZeneca vaccine, however was merely placing it on maintain.
“There may be good proof that the vaccine is each secure and efficient,” Brostrøm stated.
“However we and the Danish Medicines Company should react to studies of attainable severe unwanted effects, each from Denmark and different European nations. It reveals that the surveillance system is working.”
A senior official on the Nationwide Institute of Public Well being, Geir Bukholm, instructed reporters on Thursday afternoon: “We’re taking a break in Norway after vaccination with AstraZeneca.”
“We’re awaiting info to see if there’s a hyperlink between the vaccination and this case of blood clots.
“That is the precautionary precept,” stated Bukholm, stressing that no hyperlink had but been established between the vaccine from the Anglo-Swedish laboratory and the instances of thrombosis, together with one deadly, reported in Denmark.
What did different nations say?
In an announcement issued in response to the Danish announcement, the UK authorities stated “individuals ought to all the time go and get their COVID-19 vaccine when requested to take action.”
“It has not been confirmed that the report of a blood clot in Denmark was attributable to the COVID-19 AstraZeneca vaccine,” stated Dr Phil Bryan, security officer on the Human Rights Regulatory Company. medicine and well being merchandise.
“Blood clots can happen naturally and should not unusual. Greater than 11 million doses of the COVID-19 Vaccine AstraZeneca vaccine have now been administered throughout the UK.
“Studies of blood clots obtained up to now aren’t any higher than the quantity that will have occurred naturally within the vaccinated inhabitants,” he added.
French Well being Minister Olivier Véran instructed a late afternoon press convention that in response to the nation’s Excessive Authority for Well being “there isn’t a purpose to droop vaccinations with AstraZeneca “.
“Out of 5 million Europeans [vaccinated with AstraZeneca], 30 individuals suffered from blood clots.
“This doesn’t represent an extra of statistical threat. Out of 5 million unvaccinated Europeans, 30 of them are anticipated to have blood clots. What we name the benefit-risk ratio outweighs the danger. at this level, and investigations are ongoing, “he instructed reporters.
The AstraZeneca COVID-19 vaccine has obtained loads of consideration and headlines in EU nations in latest months. Earlier this 12 months, forward of its approval within the European Union, the corporate stated it will not be capable of ship the promised doses to member states within the first quarter of the 12 months.
The announcement sparked a bitter row with the European Fee, prompting the EU to concern new export laws on coronavirus vaccines.
After the vaccine was authorised, some nations then stated they’d not advocate it to older individuals, citing a lack of knowledge on individuals over 65 within the trial. Nonetheless, the European Medicines Company has beneficial that the vaccine be approved for anybody over the age of 18.